Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

PRP improves hair thickness for both genders, but only increases hair density in men.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Dutasteride is a safe and effective treatment for hair loss.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Polyamines help fix DNA damage accurately in cells.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Better standardization and transparency in statistical reporting are needed to improve hair care research quality.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.